Steven’s Story
My name is Steven Hadfield. I am 70 years old, a long-time North Carolinian, a husband, a grandfather of three, and a football fanatic. I’m also a rare cancer and type 2 diabetes patient.
The current drug pricing system isn’t working for patients like me.
My name is Emily. I’m a 26-year-old from Washington, D.C., and I live with psoriatic arthritis.
The pharmaceutical industry preys on families.
If Medicare were able to negotiate drug prices, then all seniors would be given the relief they deserve. The time for change is now.
The time for change is now
If Medicare were able to negotiate drug prices, then all seniors would be given the relief they deserve. The time for change is now.
The prices of their medications could impact their dreams.
Many parents of kids who need insulin have to caution their children from a young age to make life decisions based on affording their insulin including choosing their careers due to insurance coverage.
To keep advocating for others, I need to afford my medication.
To keep advocating for others, I need to afford my medications. But with prices so high, there are no guarantees I’ll be able to afford the medicine I need to live.
Luxury pricing for a necessity.
This insulin is currently priced at almost $300 per bottle. It is luxury pricing for a medication that I literally cannot live without.
Changes are terrifying because of the high price of insulin
I have to scrimp and save to afford to eat. But I know other senior citizens who are much worse off — some are even eating cat food to be able to afford their drugs.
